EP1501567A4
Method and device for controlling drug pharmacokinetics
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 6 May 2023, 3.4 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
6 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6
Every citation, both ways
| Reference | Relation | Cited during |
|---|---|---|
| No Search | Non-patent | Search report |
515 members in 18 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 377649P | United States of America | – | |
| 37764902 | United States of America | P | |
| 389881P | United States of America | – | |
| 38988102 | United States of America | P | |
| 0314063 | United States of America | W |
Members515
| Document | Office | Kind | |
|---|---|---|---|
| EP1092444A1 | European Patent Office (EPO) | A1 | |
| AU6409300A | Australia | A | |
| JP2001137343A | Japan | A | |
| US2001011171A1 | United States of America | A1 | |
| US2001012925A1 | United States of America | A1 | |
| US2001056263A1 | United States of America | A1 | |
| CA2413769A1 | Canada | A1 | |
| CA2413798A1 | Canada | A1 | |
| WO0202178A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO0202179A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU7026201A | Australia | A | |
| AU7585301A | Australia | A | |
| WO0209797A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU8076201A | Australia | A | |
| US2002038111A1 | United States of America | A1 | |
| US2002045858A1 | United States of America | A1 | |
| US2002068909A1 | United States of America | A1 | |
| US2002095134A1 | United States of America | A1 | |
| US2002133122A1 | United States of America | A1 | |
| CA2444391A1 | Canada | A1 | |
| US2002156453A1 | United States of America | A1 | |
| WO02083205A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO02083231A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO02083232A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US6494865B1 | United States of America | B1 | |
| US2002193740A1 | United States of America | A1 | |
| US2002193778A1 | United States of America | A1 | |
| US2002198509A1 | United States of America | A1 | |
| CA2451816A1 | Canada | A1 | |
| WO03002069A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2003014018A1 | United States of America | A1 | |
| KR20030017567A | Republic of Korea | A | |
| KR20030019464A | Republic of Korea | A | |
| EP1296740A1 | European Patent Office (EPO) | A1 | |
| EP1296742A1 | European Patent Office (EPO) | A1 | |
| US6569123B2 | United States of America | B2 | |
| US6569143B2 | United States of America | B2 | |
| EP1313520A1 | European Patent Office (EPO) | A1 | |
| US2003100885A1 | United States of America | A1 | |
| BR0112313A | Brazil | A | |
| BR0112314A | Brazil | A | |
| CA2471493A1 | Canada | A1 | |
| WO03057143A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2002360693A1 | Australia | A1 | |
| CA2474742A1 | Canada | A1 | |
| WO03002069A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO03066126A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO03066141A1 | World Intellectual Property Organization (WIPO) | A1 | |
| CN1438905A | China | A | |
| AU2002332466A1 | Australia | A1 | |
| AU2003210854A1 | Australia | A1 | |
| US2003199822A1 | United States of America | A1 | |
| CN1454104A | China | A | |
| AU2003230256A1 | Australia | A1 | |
| CA2484265A1 | Canada | A1 | |
| WO03094995A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2003220610A1 | United States of America | A1 | |
| WO03057143A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1381422A1 | European Patent Office (EPO) | A1 | |
| EP1381423A1 | European Patent Office (EPO) | A1 | |
| JP2004501724A | Japan | A | |
| JP2004501725A | Japan | A | |
| EP1385560A1 | European Patent Office (EPO) | A1 | |
| US2004023844A1 | United States of America | A1 | |
| US6689118B2 | United States of America | B2 | |
| JP2004504891A | Japan | A | |
| US2004073160A1 | United States of America | A1 | |
| CA2493728A1 | Canada | A1 | |
| WO2004032990A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003296884A1 | Australia | A1 | |
| EP1416986A2 | European Patent Office (EPO) | A2 | |
| US2004116859A1 | United States of America | A1 | |
| MXPA03011611A | Mexico | A | |
| US2004131641A1 | United States of America | A1 | |
| US2004138612A1 | United States of America | A1 | |
| WO03066126A3 | World Intellectual Property Organization (WIPO) | A3 | |
| BR0210628A | Brazil | A | |
| CN1520318A | China | A | |
| US6776776B2 | United States of America | B2 | |
| AU2004209917A1 | Australia | A1 | |
| CA2514503A1 | Canada | A1 | |
| WO2004069301A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2004069302A2 | World Intellectual Property Organization (WIPO) | A2 | |
| JP2004525712A | Japan | A | |
| JP2004525713A | Japan | A | |
| US2004175360A1 | United States of America | A1 | |
| MXPA03000134A | Mexico | A | |
| WO2004032990A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2004193110A1 | United States of America | A1 | |
| MXPA04007389A | Mexico | A | |
| JP2004531578A | Japan | A | |
| EP1467780A2 | European Patent Office (EPO) | A2 | |
| US6808506B2 | United States of America | B2 | |
| MXPA03000228A | Mexico | A | |
| KR20040093703A | Republic of Korea | A | |
| MXPA03009371A | Mexico | A | |
| WO2004098676A2 | World Intellectual Property Organization (WIPO) | A2 | |
| EP1478428A2 | European Patent Office (EPO) | A2 | |
| AU2004238257A1 | Australia | A1 | |
| CA2524444A1 | Canada | A1 |
Showing 100 of 515
61 legal events, as 9 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent expired after termination of 20 yearsExpiredPE20 | PE20 | GB | |
| Expiry of rightR071 | R071 | DE | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent lapsedLapsedMM4A | MM4A | IE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| Lapsed because of non-payment of the annual feeLapsedMM | MM | BE | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097 | R097 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Deletion acc. to par. 5 (withdrawal of the translation of the ep patent)MK05 | MK05 | AT | |
| Patent invalid in the netherlands as no translation has been filedMP | MP | NL | |
| Fee paymentPLFP | PLFP | FR | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| Dpma publication of mentioned ep patent grantGrantedR096 | R096 | DE | |
| Reference to at number (ep patent validated in austria)REF | REF | AT | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE PATENT HAS BEEN GRANTEDSTAA | STAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Intention to grant announcedINTG | INTG | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: GRANT OF PATENT IS INTENDEDSTAA | STAA | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: EXAMINATION IS IN PROGRESSSTAA | STAA | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Supplementary search report drawn up and despatchedA4 | A4 | EP | |
| Request for extension of the european patent (deleted)DAX | DAX | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1501567
- Application
- 37244548
Titles3
- German
- VERFAHREN UND VORRICHTUNG ZUR KONTROLLE DER ARZNEIMITTEL-PHARMAKOKINETIK
- English
- METHOD AND DEVICE FOR CONTROLLING DRUG PHARMACOKINETICS
- French
- METHODE ET DISPOSITIF DE CONTROLE PHARMACOCINETIQUE DE MEDICAMENTS
Classification
- CPC, 4
- A61M37/0015
- A61M2037/0023
- A61M2037/0061
- A61M5/3291
- IPC, 5
- A61K31 00
- A61M5 32
- A61M1 00
- A61M31 00
- A61M37 00
Designated states27
- Contracting states, 27
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Hungary
- Ireland
- Italy
- Liechtenstein
- Luxembourg
- Monaco
- Netherlands (Kingdom of the)
- Portugal
- Romania
- Sweden
and 3 moreShow fewer
- Slovenia
- Slovakia
- Türkiye